Phase 1 pharmacokinetic (PK) study of CT-2103 given Q2 or Q3 weeks in patients with solid tumors

Dr Mark Verrill; Professor Alan Boddy; Julieann Sludden; Kevin Fishwick; Lynsey Robson; Dr Jane Cassidy; Professor Alan Calvert

Phase 1 pharmacokinetic (PK) study of CT-2103 given Q2 or Q3 weeks in patients with solid tumors Lookup NU author(s) Dr Mark Verrill Professor Alan Boddy Julieann Sludden Kevin Fishwick Lynsey Robson Dr Jane Cassidy Professor Alan Calvert



Author(s)		Verrill MW, Boddy AV, Todd R, Sludden J, Fishwick KA, Robson L, Cassidy J, Bissett D, Calvert AH
Editor(s)
Publication type		Conference Proceedings (inc. Abstract)
Conference Name		Proceedings of the 39th Annual Meeting of The Americal Society of Clinical Oncology
Conference Location		Chicago, Illinois, USA
Year of Conference		2003
Date		31-05-2003 - 03-06-2003
Volume		22
Pages		A 533



Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



Publisher		American Society of Clinical Oncology
URL		http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=23&abstractID=104018